Some visit links earn us a commission.
Quick verdict
9amHealth is the better pick for most patients on overall scoring. 9amHealth treats GLP-1 as one tool inside a broader cardiometabolic program. Strong employer and insurance relationships, branded-first medication strategy, labs included. Best fit for patients with comorbidities, not pure weight-loss buyers.
That said, Hims & Hers wins on specific dimensions. Same-day prescription, no lock-in and brand-name confidence. Hims pivoted to branded-only in March 2026 after settling with Novo Nordisk; compounded semaglutide is closed to new patients. Headline price is $299/mo branded Wegovy injectable (self-pay), plus $149/mo membership.
Side-by-side
| Hims & Hers | 9amHealth | |
|---|---|---|
| Starts from | $299/mo (incl. medication) | $649/mo (incl. medication) |
| Monthly cost gap | Hims & Hers is $350/mo cheaper than 9amHealth | |
| Lock-in | Month-to-month | Month-to-month |
| Time to prescription | 1 day | 5 days |
| Consultation type | Asynchronous | Live |
| Affiliate network | Impact | Direct |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Hims & Hers | 9amHealth | |
|---|---|---|
| Pricing transparency | 6/10 | 7/10 |
| Cancellation terms | 9/10 | 8/10 |
| Onboarding experience | 9/10 | 6/10 |
| Medication options | 5/10 | 7/10 |
| Member reviews | 6/10 | 8.4/10 |
When to choose Hims & Hers
Best for fast async onboarding
Patients who want a fast, low-friction async path to a branded GLP-1 prescription with predictable monthly pricing.
Hims & Hers wins on cancellation terms, onboarding experience and runs $350/mo cheaper than 9amHealth at the entry tier ($299 vs $649). Over a year that's $4,200 you keep. The caveat: Patients who wanted Hims's old compounded semaglutide tier or who need insurance-routed branded access. Compounded is closed to new patients. Note also: Settled with Novo Nordisk March 9, 2026 over compounded semaglutide marketing
When to choose 9amHealth
Best for diabetes and cardio risk
Patients with diabetes, prediabetes or cardiovascular risk who want GLP-1 inside full-spectrum metabolic care.
9amHealth wins on pricing transparency, medication options, member reviews on the dimensional scoring. The caveat: Healthy BMI-only patients chasing the lowest GLP-1 price.
If cost is your main filter
Hims & Hers is the cheaper monthly: $299 all-in vs $649 for 9amHealth. That's $350 a month or $4,200a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $1050 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Hims & Hers (month-to-month) and 9amHealth (month-to-month) sit at the same cancellation tier. Read both cancellation policies directly before signing; the on-page summary covers the headline but not the deletion-of-account or refund-window edge cases.
FAQ
Is Hims & Hers cheaper than 9amHealth?
Can I switch from Hims & Hers to 9amHealth mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
